Literature DB >> 33797006

A homozygous truncating variant in GDF9 in siblings with primary ovarian insufficiency.

Kunal P Verma1, Bryony Thompson2, James Wolfe3, Sarah Price4, Frida Djukiadmodjo3, Alison Trainer3.   

Abstract

Premature or primary ovarian insufficiency (POI) affects approximately 1% of women and can be due to a variety of causes. Genetic causes include syndromic and non-syndromic POI. There are several promising candidate genes for whom a clear Mendelian association with non-syndromic POI has not yet been conclusively established, including GDF9. GDF9 is an oocyte-secreted factor and is part of the TGF-beta superfamily of morphogens. It has an important role in follicular development and granulosa cell maturation. We report the case of two siblings with primary ovarian insufficiency (POI) and a homozygous truncating variant in GDF9 (c.604C>T; p.(Gln202*). This report helps establish a clear gene-disease association between GDF9 and POI and argues for routine evaluation for GDF9 variants in patients undergoing genomic investigation for POI.

Entities:  

Keywords:  GDF9; Primary ovarian insufficiency

Mesh:

Substances:

Year:  2021        PMID: 33797006      PMCID: PMC8266936          DOI: 10.1007/s10815-021-02144-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  22 in total

Review 1.  Oocyte-expressed TGF-beta superfamily members in female fertility.

Authors:  J A Elvin; C Yan; M M Matzuk
Journal:  Mol Cell Endocrinol       Date:  2000-01-25       Impact factor: 4.102

2.  Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure.

Authors:  Hridesh Dixit; Lakshmi K Rao; Venkata Padmalatha; Murthy Kanakavalli; Mamatha Deenadayal; Nalini Gupta; Baidyanath Chakravarty; Lalji Singh
Journal:  Menopause       Date:  2005-11-08       Impact factor: 2.953

3.  Identification of the first homozygous 1-bp deletion in GDF9 gene leading to primary ovarian insufficiency by using targeted massively parallel sequencing.

Authors:  M M França; M F A Funari; M Y Nishi; A M Narcizo; S Domenice; E M F Costa; A M Lerario; B B Mendonca
Journal:  Clin Genet       Date:  2017-12-26       Impact factor: 4.438

4.  Growth differentiating factor-9 mutations may be associated with premature ovarian failure.

Authors:  Ertug Kovanci; Jan Rohozinski; Joe Leigh Simpson; Michael J Heard; Colin E Bishop; Sandra A Carson
Journal:  Fertil Steril       Date:  2006-12-06       Impact factor: 7.329

5.  Growth differentiation factor-9 is required during early ovarian folliculogenesis.

Authors:  J Dong; D F Albertini; K Nishimori; T R Kumar; N Lu; M M Matzuk
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

6.  Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) mutation in Chinese women with premature ovarian failure.

Authors:  Binbin Wang; Qiaolian Wen; Feng Ni; Sirui Zhou; Jing Wang; Yunxia Cao; Xu Ma
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-04       Impact factor: 3.478

7.  Incidence of premature ovarian failure.

Authors:  C B Coulam; S C Adamson; J F Annegers
Journal:  Obstet Gynecol       Date:  1986-04       Impact factor: 7.661

Review 8.  Clinical practice. Primary ovarian insufficiency.

Authors:  Lawrence M Nelson
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.